Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells

International Journal of Cancer

Volumn 131, Issue 9, 2012, Pages 2016-2026

  Malz, Mona ^a   Aulmann, Antje ^a   Samarin, Jana ^a   Bissinger, Michaela ^a   Longerich, Thomas ^a   Schmitt, Sabrina ^a   Schirmacher, Peter ^a   Breuhahn, Kai ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

hepatocellular carcinoma; migration; proliferation; proteasome; ubiquitin ligase

Indexed keywords

CISPLATIN; PACLITAXEL; SEVEN IN ABSENTIA HOMOLOGUE 1; SEVEN IN ABSENTIA HOMOLOGUE 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOACCUMULATION; BIOLOGICAL ACTIVITY; CANCER GROWTH; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISTANT METASTASIS; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE SILENCING; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 84865568783     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27473     Document Type: Article

References (40)

1. Pickart CM, Cohen RE,. Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 2004; 5: 177-87. (Pubitemid 38325799)
2. Sadowski M, Sarcevic B,. Mechanisms of mono- and poly-ubiquitination: ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine. Cell Div 2010; 5: 19.
3. Yang Y, Kitagaki J, Wang H, Hou DX, Perantoni AO,. Targeting the ubiquitin-proteasome system for cancer therapy. Cancer Sci 2009; 100: 24-8.
4. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, Dunham MJ, Amon A,. Identification of aneuploidy-tolerating mutations. Cell 2010; 143: 71-83.
5. Wilkens L, Flemming P, Gebel M, Bleck J, Terkamp C, Wingen L, Kreipe H, Schlegelberger B,. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci USA 2004; 101: 1309-14. (Pubitemid 38182685)
6. Nag A, Bagchi S, Raychaudhuri P,. Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res 2004; 64: 8152-5. (Pubitemid 39491749)
7. Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, Schule B, Klein C, Shridhar V, Roberts LR, Smith DI,. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer 2004; 40: 85-96. (Pubitemid 38579877)
8. Kim GP, Mahoney MR, Szydlo D, Mok TS, Marshke R, Holen K, Picus J, Boyer M, Pitot HC, Rubin J, Philip PA, Nowak A, et al. An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Invest New Drugs 2012; 30: 387-94.
9. Espinosa A, Oke V, Elfving A, Nyberg F, Covacu R, Wahren-Herlenius M,. The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide. Exp Cell Res 2008; 314: 3605-13.
10. Kao SY,. DNA damage induces nuclear translocation of parkin. J Biomed Sci 2009; 16: 67.
11. Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A, Riener MO, Soll C, Samarin J, Bissinger M, Schmidt J, Longerich T, Ehemann V, et al. Nuclear expression of the ubiquitin ligase seven in absentia homologue (SIAH)-1 induces proliferation and migration of liver cancer cells. J Hepatol 2011; 55: 1049-57.
12. Hu G, Chung YL, Glover T, Valentine V, Look AT, Fearon ER,. Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics 1997; 46: 103-11. (Pubitemid 27527697)
13. Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S,. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci USA 2004; 101: 5500-5. (Pubitemid 38481186)
14. Dickins RA, Frew IJ, House CM, O'Bryan MK, Holloway AJ, Haviv I, Traficante N, de Kretser DM, Bowtell DD,. The ubiquitin ligase component Siah1a is required for completion of meiosis I in male mice. Mol Cell Biol 2002; 22: 2294-303. (Pubitemid 34224634)
15. Frew IJ, Hammond VE, Dickins RA, Quinn JM, Walkley CR, Sims NA, Schnall R, Della NG, Holloway AJ, Digby MR, Janes PW, Tarlinton DM, et al. Generation and analysis of Siah2 mutant mice. Mol Cell Biol 2003; 23: 9150-61. (Pubitemid 37499804)
16. Moller A, House CM, Wong CS, Scanlon DB, Liu MC, Ronai Z, Bowtell DD,. Inhibition of Siah ubiquitin ligase function. Oncogene 2009; 28: 289-96.
17. Schleger C, Heck R, Niketeghad F, Schirmacher P, Radaeva S, Oesch F, Dienes HP, Bannasch P, Steinberg P,. Establishment and characterization of a nontumorigenic cell line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. Exp Cell Res 1997; 236: 418-26. (Pubitemid 27505594)
18. Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, Kleeff J, Ehemann V, Eils R, Lichter P, Schirmacher P, Radlwimmer B,. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008; 47: 511-20. (Pubitemid 351280719)
19. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, Breuhahn K,. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 2007; 46: 759-68. (Pubitemid 47436122)
20. Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener MO, Longerich T, Soll C, Vogel A, Angel P, Schirmacher P, Breuhahn K,. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology 2009; 50: 1130-9.
21. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P,. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 2003; 201: 250-9. (Pubitemid 37258936)
22. Chan P, Moller A, Liu MC, Sceneay JE, Wong CS, Waddell N, Huang KT, Dobrovic A, Millar EK, O'Toole SA, McNeil CM, Sutherland RL, et al. The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression. Breast Cancer Res 2011; 13: R19.
23. Frew IJ, Dickins RA, Cuddihy AR, Del Rosario M, Reinhard C, O'Connell MJ, Bowtell DD,. Normal p53 function in primary cells deficient for Siah genes. Mol Cell Biol 2002; 22: 8155-64. (Pubitemid 35304049)
24. Famulski JK, Trivedi N, Howell D, Yang Y, Tong Y, Gilbertson R, Solecki DJ,. Siah regulation of Pard3A controls neuronal cell adhesion during germinal zone exit. Science 2010; 330: 1834-8.
25. Qi J, Nakayama K, Gaitonde S, Goydos JS, Krajewski S, Eroshkin A, Bar-Sagi D, Bowtell D, Ronai Z,. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proc Natl Acad Sci USA 2008; 105: 16713-8.
26. Ahmed AU, Schmidt RL, Park CH, Reed NR, Hesse SE, Thomas CF, Molina JR, Deschamps C, Yang P, Aubry MC, Tang AH,. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst 2008; 100: 1606-29.
27. Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA,. Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res 2009; 22: 799-808.
28. El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76. (Pubitemid 46890874)
29. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-90.
30. Petroski MD, Deshaies RJ,. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6: 9-20. (Pubitemid 40064895)
31. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005; 7: 665-74. (Pubitemid 40975747)
32. Mekhail K, Khacho M, Carrigan A, Hache RR, Gunaratnam L, Lee S,. Regulation of ubiquitin ligase dynamics by the nucleolus. J Cell Biol 2005; 170: 733-44. (Pubitemid 41242106)
33. Naishiro Y, Adachi M, Okuda H, Yawata A, Mitaka T, Takayama S, Reed JC, Hinoda Y, Imai K,. BAG-1 accelerates cell motility of human gastric cancer cells. Oncogene 1999; 18: 3244-51. (Pubitemid 29286969)
34. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, Kadoya T, Erdjument-Bromage H, Tempst P, Frappell PB, Bowtell DD, Ronai Z,. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 2004; 117: 941-52. (Pubitemid 38798859)
35. Li H, Ge C, Zhao F, Yan M, Hu C, Jia D, Tian H, Zhu M, Chen T, Jiang G, Xie H, Cui Y, et al. HIF-1α-activated ANGPTL4 contributes to tumor metastasis via VCAM-1/integrin β1 signaling in human hepatocellular carcinoma. Hepatology 2011; 54: 910-19.
36. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST,. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 2008; 29: 2096-105.
37. 2-regulated prolyl hydroxylation. Science 2001; 292: 468-72. (Pubitemid 32335942)
38. Yun S, Moller A, Chae SK, Hong WP, Bae YJ, Bowtell DD, Ryu SH, Suh PG,. Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase Cε. J Biol Chem 2008; 283: 1034-42.
39. Kane RC, Farrell AT, Sridhara R, Pazdur R,. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin Cancer Res 2006; 12: 2955-60. (Pubitemid 43837337)
40. Sloss CM, Wang F, Liu R, Xia L, Houston M, Ljungman D, Palladino MA, Cusack JC Jr,. Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells. Clin Cancer Res 2008; 14: 5116-23.